Inventor
Dieter Petzinna
Inventor
Duesseldorf, DE
Overview
Patents· 27 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds48%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations34%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium14%
C07CAcyclic or carbocyclic compounds4%
PatentTitleYear
5,502,057'Polysubstituted pyridines useful for treating lipoproteinanaemia and arteriosclerosis'19965,470,982'Disubstituted pyridines'19955,401,746'Substituted pyridines heptenoic acid derivatives, useful for treating arterioscleros, lipopotaemia and the like'19955,183,897'Certain intermediate imino-substituted pyridines'19935,177,080'Substituted pyridyl-dihydroxy-heptenoic acid and its salts'19935,173,495'7-[(2,6-dialkyl-4-furyl or thienyl-pyridyl)]-3,5-di-(dihydroxy-6-enoates) useful for treating circulatory diseases'19925,169,857'7-(polysubstituted pyridyl)-hept-6-endates useful for treating hyperproteinaemia, lipoproteinaemia or arteriosclerosis'19925,164,506'Substituted 2-pyridones and pyrid-2-thiones compounds'19925,145,959'Substituted pyrido (2,3-d) pyrimidines as intermediates'19925,145,857'HMG-COA reductase-inhibiting substituted amino-pyridines'19925,075,311'HMG-CoA reductase inhibiting substituted pryido (2,3-d) pyrimidines'19915,064,841'HMG-COA reductase-inhibiting imino-substituted pyridines'19915,034,399'Substituted 1,8-naphthyridines and their use in medicaments'19915,032,602'Inhibiting HMG-CoA reductase with novel substituted 2-pyridones and pyrid-2-thiones'19915,032,590'Substituted hydroxylamines'19915,026,714'Novel 1-alkyl-substituted 1,4-dihydropyridinelactone anti-diabetics'19915,006,530'Certain 7-[2,6-diisopropyl-4-phenyl-5-lower alkoxymethyl-pyrid-3-yl]-3,5-dihydroxy-6-enoates and derivatives useful for treating circulatory diseases'19914,992,462'Substituted pyrroles'19914,988,711'HMG-CoA reductare-inhibiting N-substituted N-amino-pyrroles'19914,973,598'Substituted imidazolinones and imidazolinethiones'19904,968,689'Certain 2,6-diisopropyl-4-(4-fluoro-phenyl)-3,5-bis-dimethyl-3\',5\'-dihydroxy-hep t-6-enoate-pyridine derivatives useful for treating lipoproteinaemia and arteriosclerosis'19904,968,681'Substituted hydroxylamines'19904,937,255'Disubstituted pyrroles'19904,894,378'Lowering blood sugar with novel 4-thienyl-dihydropyridines'19904,801,715'Certain 4-thienyl-dihydropyridines'19894,786,641'Dihydropyridine compounds and their use in reducing blood sugar'19884,721,719'Dihydropyridinelactols and their use as medicaments which influence blood sugar'1988Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1988–1996Patents assigned to BAYER AG (27)· patent assignee history
1988–1995Based in Duesseldorf, DE· patent location history
1988–1991Based in Wesel, DE· patent location history
1990Based in Duesseldorlf, DE· patent location history
1995Based in Dusseldorf, DE· patent location history
1996Based in Du/ sseldorf, DE· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BAYER AG | 27 | 1988–1996 |
Locations
| Location | Patents | Span |
|---|---|---|
| Duesseldorf, DE | 20 | 1988–1995 |
| Wesel, DE | 4 | 1988–1991 |
| Du/ sseldorf, DE | 1 | 1996 |
| Dusseldorf, DE | 1 | 1995 |
| Duesseldorlf, DE | 1 | 1990 |